The goal of this activity is for oncologists and other clinicians who care for patients with metastatic CRC to be better able to sequence oral TKI therapies in an effort to enhance patient outcomes.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/optimizing-sequencing-oral-tyrosine-kinase-inhibitors-2023a1000xbv
- Start Date: 2024-04-15 05:00:00
- End Date: 2024-04-15 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bayer (Any division) - Amount: 133500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Gastroenterology, Hematology, Medical Oncology
Subscribe
Login
0 Comments
Oldest